These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 5369241)
41. [Use of the new psychotropic preparation bemitil in treating asthenic disorders (clinico-pharmacological research)]. Aleksandrovskiĭ IuA; Bobkov IuG; Neznamov GG; Serebriakova TV; Boĭko SS Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(3):109-15. PubMed ID: 3381606 [TBL] [Abstract][Full Text] [Related]
42. [Extension of therapeutic possibilities by a new tranquilizer]. Leube H Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250 [No Abstract] [Full Text] [Related]
43. [Neurological analysis of the action of tranquilizing agents--benzodiazepine derivatives]. Aleksandrovskiĭ IuA; Bragina NN; Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(5):736-42. PubMed ID: 4341577 [No Abstract] [Full Text] [Related]
44. Differential response to psychotropic drugs. Johnson G; Gershon S Compr Psychiatry; 1971 Sep; 12(5):399-413. PubMed ID: 4399193 [No Abstract] [Full Text] [Related]
45. [The basic criteria for clinical evaluation of the effect of tranquilizers]. Aleksandrovskiĭ IuA Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1873-82. PubMed ID: 5511527 [No Abstract] [Full Text] [Related]
46. [Mental patients in general practice. A diagnostic, sociological, and therapeutic study]. Agosti E; Agosti F; Ernst K Schweiz Med Wochenschr; 1974 Mar; 104(9):322-5. PubMed ID: 4819674 [No Abstract] [Full Text] [Related]
47. The present status of psychotropic drugs. Dally P Practitioner; 1970 Sep; 205(227):307-12. PubMed ID: 5484906 [No Abstract] [Full Text] [Related]
48. [Drug therapy of child behavior disorders]. Corboz RJ Wien Med Wochenschr; 1969 Jul; 119(30):540-7. PubMed ID: 5351661 [No Abstract] [Full Text] [Related]
50. [Use of lithium carbonate in a psychiatric institution]. Duflot JP; Dore C; Fellion G; Kamba A; Morin F; Balland Ann Med Psychol (Paris); 1973 Jul; 2(2):311-21. PubMed ID: 4787817 [No Abstract] [Full Text] [Related]
51. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1980 Sep; 22(19):77-84. PubMed ID: 6106886 [No Abstract] [Full Text] [Related]
52. [Psychotherapy in psychiatric practice (author's transl)]. Nedelmann C Nervenarzt; 1982 Jan; 53(1):33-8. PubMed ID: 7057956 [No Abstract] [Full Text] [Related]
53. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Curran S; Turner D; Musa S; Wattis J Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576 [TBL] [Abstract][Full Text] [Related]
54. [Effect of luliberin in the treatment of mental disorders in cerebral arteriosclerosis]. Tikhomirov SM; Bakharev VM Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):121-3. PubMed ID: 2158710 [TBL] [Abstract][Full Text] [Related]
55. Haloperidol and the butyrophenones. Ban TA Psychosomatics; 1973; 14(5):286-97. PubMed ID: 4604517 [No Abstract] [Full Text] [Related]
56. Drugs in geropsychiatry. Petrie WM; Ban TA Psychopharmacol Bull; 1978 Oct; 14(4):7-19. PubMed ID: 360264 [No Abstract] [Full Text] [Related]
57. [The problem of preclinical evaluation of psychotropic drugs]. Tansella M; Dello Russo G Acta Neurol (Napoli); 1969; 24(6):877-91. PubMed ID: 5378619 [No Abstract] [Full Text] [Related]
58. [The semiology of motor function disorders during treatment with neuroleptic drugs]. Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943 [No Abstract] [Full Text] [Related]
59. Settling characteristics of red cells in mental patients. Stevens JD Dis Nerv Syst; 1971 Aug; 32(8):554-8. PubMed ID: 5094161 [No Abstract] [Full Text] [Related]